APTAMER GROUP
The Aptamer group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, diagnostics or therapeutic developments. Aptamers are short DNA or RNA sequences that offer high-affinity and specificity to virtually all types of targets. They can therefore be thought of as synthetic nucleic acid equivalents of antibodies. Aptamers are versatile, cost effective and offer a complementary or alternative solut... ion to antibodies. We have over 20 years combined expertise in the development of nucleic acid aptamers to peptides, proteins, cells, tissue samples, micro-organisms and small molecules. The Aptamer Group of companies has cutting edge platforms for the selection of aptamers. These include semi-automated selection platforms which ensure accurate replication of selection conditions to ensure the best quality aptamers result. We can use a wide range of targets: peptide, proteins, whole cells, viruses, small molecules etc. The typical aptamer selection process can be completed in a matter of weeks. Monoclonal antibodies usually take several months to generate. Our custom service can be focussed on a particular application so that the resultant aptamers are pre-optimized for use with a given detection platform, sample type and assay buffer. Aptamers themselves are increasingly being perceived as the state of the art reagent of choice for a wide range of applications including: Imaging experiments: fluorescence, bright field and phase contrast, IHC, ICC Quantification: ELISA (or ELONA), homogeneous assays etc. Rapid diagnostics: Lateral flow devices, biosensors, electrochemical detection, nano-wires Binding studies: label free detection, SPR, Biolayer Interferometry Purification: affinity chromatography We also offer an aptamer based assay development service. Our solution can be used to identify aptamers for virtually any application and against almost any target in almost any condition. Our applications are more diverse than those for which antibodies have been used. These include therapeutics, in biomarker discover, in drug target discovery, as diagnostics, in biosensors as components of biochemical tests such as Lateral flow devices, enzyme linked oligonucleotide assays (ELONA: the aptamer based equivalent of ELISA), in affinity chromatography and as research reagents. For more information visit: www.aptamergroup.com
APTAMER GROUP
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2008-04-12
Address:
York, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.aptamergroup.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0) 1904 567 790
Email Addresses:
[email protected]
Total Funding:
8.42 M USD
Technology used in webpage:
Person Schema Facebook Sharer Gravatar Profiles Pinterest German Server Location Reddit
Similar Organizations
AltheaDx
AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Molecular Health
Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Radius Health
Radius Health develops drug therapies for osteoporosis and womenโs health.
Current Employees Featured
Founder
Stock Details
Investors List
Nicholas Slater
Nicholas Slater investment in Post-IPO Equity - Aptamer Group
Adam Hargreaves
Adam Hargreaves investment in Post-IPO Equity - Aptamer Group
Eurostars
Eurostars investment in Grant - Aptamer Group
Meneldor
Meneldor investment in Series A - Aptamer Group
BIF Partners
BIF Partners investment in Series A - Aptamer Group
Key Employee Changes
Date | New article |
---|---|
2021-06-10 | Aptamer Group appoints Jordan Clark as Chief Commercial Officer |
Official Site Inspections
http://www.aptamergroup.com Semrush global rank: 11.54 M Semrush visits lastest month: 156
- Host name: 6.17.214.35.bc.googleusercontent.com
- IP address: 35.214.17.6
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043

More informations about "Aptamer Group"
Aptamer Group (AIM:APTA) Company Profile & Description
May 27, 2025 Company profile for Aptamer Group PLC (AIM:APTA) with a description, list of executives, contact details and other key facts.See details»
APTAMER GROUP PLC APTA Our story - London Stock Exchange
Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. โฆSee details»
Aptamer Group - Crunchbase Company Profile
Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.See details»
Aptamer Group Information - RocketReach
Aptamer Group is a Biotechnology, Biotechnology Research, and Bio-Marker Discovery company located in York, England with 36 employees. Find top employees, contact details and business โฆSee details»
Aptamer Group - Overview, News & Similar companies
Jul 31, 2023 View Aptamer Group (www.aptamergroup.com) location in North Yorkshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as โฆSee details»
Aptamer Group - biosciencetechnology.com
The Aptamer group brings together various aptamer technology driven companies to provide a range of services to the life sciences industry. We develop nucleic acid aptamers for use in โฆSee details»
Aptamer Group - Craft
Aptamer Group has 5 employees across 2 locations. See insights on Aptamer Group including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aptamer Group 2025 Company Profile: Stock โฆ
Information on stock, financials, earnings, subsidiaries, investors, and executives for Aptamer Group. Use the PitchBook Platform to explore the full profile.See details»
Investor Relations - Aptamer Group
Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, andSee details»
The Aptamer Group - VentureRadar
Aptamer Group Limited United Kingdom Privately Held Aptamer Group is a world-leading provider of custom aptamer selection and development services. We utilise our many years of โฆSee details»
Aptamer Group - 2025 Company Profile - Tracxn
Mar 12, 2025 Aptamer Group - Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development. Public Company. Raised a total funding of $2.2M over 4 rounds from โฆSee details»
Aptamer Group - InsideScientific
Mar 21, 2024 Aptamer Group is the developer of custom affinity tools for the life science industry through its proprietary Optimer ® platform.See details»
Aptamer Group - Neuroscience 2023
Nov 15, 2023 Aptamer Group develops custom affinity binders for use across the life sciences using its proprietary Optimer® platform. Optimer affinity ligands are oligonucleotide-based โฆSee details»
The Team - Aptamer Group
Windmill House, Innovation Way, York, YO10 5BR, UK Tel: +44 (0) 1904217404 Email: [email protected]See details»
Aptamer Group Overview | SignalHire Company Profile
The Aptamer group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, โฆSee details»
About - Aptamer Group
At Aptamer Group, we have successfully delivered projects for global pharma companies, diagnostic development companies, and research institutes covering a range of targets and โฆSee details»
Reports And Presentations - Aptamer Group
Full results for the year ended 30 June 2024 presentation slides Full results for the year ended 30 June 2024 presentation videoSee details»
Is Aptamer Groupโs Optimer the Future of Liver Disease Treatment?
Apr 26, 2024 The Rise of Aptamer TechnologyLiver diseases, particularly fibrotic disorders, represent a significant health burden worldwide. The quest for more effective therapies has led โฆSee details»
Aptamer Group - Profiles & Contacts - Crunchbase
Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.See details»
Aptorum Group Limited and DiamiR Biosciences Enter into
2 days ago Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement July 16, 2025 08:38 ET | Source: Aptorum Group Ltd FollowSee details»